100% Quality Guarantee
PhD-Level Technical Support
Human Cell Biology ELISA Kits 4 Human IFNAR1 / Interferon alpha / beta receptor 1 ELISA Kit
Key Features

Human IFNAR1/Interferon alpha/beta receptor 1 ELISA Kit (HUFI01301)

SKU HUFI01301
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 0.094 ng/mL
Range 0.156-10 ng/mL
€649

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human IFNAR1/Interferon alpha/beta receptor 1 ELISA Kit

The Human IFNAR1 (Interferon Alpha-Beta Receptor 1) ELISA Kit is specifically designed for the precise measurement of IFNAR1 levels in human serum, plasma, and cell culture supernatants. This kit offers exceptional sensitivity and specificity, guaranteeing accurate and consistent results, making it an essential tool for various research applications. IFNAR1 is a critical receptor involved in mediating the effects of interferons, key players in the immune response against viral infections and tumors.

Dysregulation of IFNAR1 signaling has been implicated in various autoimmune diseases, viral infections, and cancer, highlighting its importance as a potential therapeutic target and biomarker for disease progression and treatment efficacy. Overall, the Human IFNAR1 ELISA Kit provides researchers with a valuable tool for studying the role of IFNAR1 in immune responses, infectious diseases, and cancer, ultimately contributing to the development of novel therapies and diagnostic strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose